| Literature DB >> 33505625 |
Chieh-Yuan Cheng1,2,3, Fang-Ju Sun4, Chung-Ji Liu1,2,3.
Abstract
BACKGROUND/Entities:
Keywords: Lymph nodes number; Oral cancer; Prognosis; Survival
Year: 2020 PMID: 33505625 PMCID: PMC7816029 DOI: 10.1016/j.jds.2020.06.002
Source DB: PubMed Journal: J Dent Sci ISSN: 1991-7902 Impact factor: 2.080
Demographics and clinical pathological characteristics of T1, T2 N0 oral cancer patients (total 126 cases) with neck dissection.
| N (%) | |
|---|---|
| Age | 52.9 (30–87) |
| Sex | |
| Male | 112 (88.9) |
| Female | 14 (11.1) |
| Location | |
| Tongue | 52 (41.3) |
| Buccal | 51 (40.5) |
| Gum | 10 (7.9) |
| Palate | 8 (6.3) |
| Other | 5 (4.0) |
| T & Stage classification | |
| I | 43 (34.1) |
| II | 83 (65.9) |
| Depth of invasion | Mean = 5.24 mm (0.5–23 mm) |
| Differentiation | |
| Well | 55 (43.7) |
| Moderate | 65 (51.6) |
| Poor | 6 (4.7) |
| Nerve invasion | |
| N- | 115 (91.3) |
| N+ | 11 (8.7) |
| Vascular invasion | |
| V- | 124 (98.4) |
| V+ | 2 (1.6) |
| Radiotherapy | |
| Negative | 110 (87.3) |
| Positive | 16 (12.7) |
| Recurrent | |
| Negative | 112 (88.9) |
| Positive | 14 (11.1) |
| Prognosis | |
| Survival | 115 (91.3) |
| Expired | 11 (8.7) |
Univariable and multivariable analysis for T1, T2 N0 oral cancer patients.
| Expired 11 | Univariable (Cox regression analysis) | Multivariable | ||
|---|---|---|---|---|
| Hazard Ratios (95% CI) | Hazard Ratios (95% CI) | |||
| Tumor size | ||||
| T1 | 1.0 | 0.822 | ||
| T2 | 1.165 (0.308–4.407) | |||
| Radiotherapy | ||||
| Yes | 4.844 | |||
| No | 1.0 | 0.012∗ | ||
| Age | 0.981 (0.929–1.034) | 0.471 | ||
| Differentiation | ||||
| Well | 1.0 | |||
| Moderate | 3.086 (0.641–14.860) | 0.160 | ||
| Poor | 12.728 (1.788–90.593) | 0.011∗ | 12.845 (1.655–99.677) | 0.015∗ |
| Tumor thickness | 1.093 | 0.253 | ||
| Nerve invasion | ||||
| (+) | 19.957 | <0.001∗∗∗ | 14.496 (3.486–60.272) | <0.001∗∗∗ |
| (−) | 1 | |||
| Vascular invasion | ||||
| (+) | 7.459 | 0.057 | ||
| (−) | 1.0 | |||
| Lymph nodes number/each level | ||||
| I | 0.974 | 0.749 | ||
| II | 0.875 | 0.087 | ||
| III | 0.924 | 0.306 | ||
| IV | 1.002 | 0.979 | ||
| V | 0.859 | 0.320 | ||
| Lymph nodes (Total number) | 0.953 (0.885–0.988) | 0.017∗ | 0.935 (0.876–0.998) | 0.044∗ |
| Recurrent | ||||
| Yes | 1.139 | 0.869 | ||
| No | 1.0 | |||
∗ Statistically significant (P < 0.05). ∗∗∗ statistically significant (P < 0.001).
Figure 1Unpaired t test showing no difference in the number of examined neck lymph nodes between the nodal positive and nodal negative oral cancer groups; p = 0.89.
Figure 2Mann Whitney test showing significant difference in the total examined lymph nodes number between the total survival and total expired groups of pT1, T2N0 oral cancer patients; p = 0.038; 1S: neck level 1 survival group; 1E: neck level 1 expired group; 2S: neck level 2 survival group; 2E: neck level 2 expired group; 3S: neck level 3 survival group; 3E: neck level 3 expired group; 4S: neck level 4 survival group; 4E: neck level 4 expired group; 5S: neck level 5 survival group; 5E: neck level 5 expired group; Total survival: total neck level of the survival group; Total expired: total neck level of the expired group.
Figure 3Kaplan–Meier curves showing a significant difference in survival between the total retrieved lymph nodes number ≥37 and < 37; p = 0.019.
Demographics and clinical pathological characteristics of early stage oral cancers on different locations.
| Total | Tongue | Buccal | Gum | Palate | Other | ||
|---|---|---|---|---|---|---|---|
| Cases (N) | 126 | 52 | 51 | 10 | 8 | 5 | |
| Mean age, years | 52.9 | 50.6 | 52.5 | 54.7 | 65.6 | 58.4 | |
| (30–87) | (30–83) | (31–87) | (31–71) | (52–80) | (47–67) | ||
| LNs (N) | 33 | 34.0 | 30.6 | 34.4 | 40.5 | 28.8 | |
| Recurrent (N) | 14 | 6 | 6 | 1 | 1 | 0 | |
| Mean, months | 26.8 | 27.6 | 26.2 | 31 | 17 | 0 | |
| (8–58) | (12–53) | (8–58) | 31 | 17 | |||
| Mean survival | 115/126 | 46/52 | 48/51 | 8/10 | 8/8 | 5/5 | |
| (91.3%) | (88.5%) | (94.1) | (80%) | (100%) | (100%) |
LNs: lymph nodes; Other: including mouth floor and lips.
Figure 4Unpaired t test showing significant difference in survival and expired between the ND and W&S groups of the T1, T2 N0 oral cancer patients; p = 0.005; ND: neck dissection; W&S: watch-and-see.